AMERIPRISE FINANCIAL INC

Position in CRBU — Caribou Biosciences, Inc.

CIK 820027 MINNEAPOLIS, MN

Position in CRBU

as of Mar 31, 2026 · filed May 15, 2026 Compact

Position Value

$55,917

-$79,398 QoQ

Shares Held

29,430

-65.4% QoQ

Ownership

0.030%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

#70

of 137 holders

Holding Since

Sep 2022

13 quarters on record

Voting authority Sole 0.ToString("F0")% Shared 100.ToString("F0")% None 0.ToString("F0")%

Healthcare · as of Mar 31, 2026

AMERIPRISE FINANCIAL INC holds $4,230,069,783 across 189 Biotechnology names. CRBU ranks #184 (0.0% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	VRTX	Vertex Pharmaceuticals Inc / Ma	2,633,481	$1,175,954,602
2	INSM	INSMED Inc	3,057,718	$499,998,043
3	JAZZ	Jazz Pharmaceuticals plc	1,608,476	$304,082,386
4	REGN	Regeneron Pharmaceuticals, Inc.	319,677	$246,995,233
5	ARGX	Argenx SE	215,910	$157,668,275
6	RVMD	Revolution Medicines, Inc.	1,579,793	$153,634,868
7	ASND	Ascendis Pharma A/S	476,466	$108,982,067
8	BBIO	BridgeBio Pharma, Inc.	1,248,521	$92,715,166

13 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$55,917	29,430	-65.4%	Shares	Defined	2026-05-15
2025-12-31	$135,315	85,104	-0.3%	Shares	Defined	2026-02-17
2025-09-30	$198,874	85,354	-72.4%	Shares	Defined	2025-11-14
2025-06-30	$389,283	308,955	-24.3%	Shares	Defined	2025-08-14
2025-03-31	$372,556	408,058	0.0%	Shares	Defined	2025-05-14
2024-12-31	$648,812	408,058	+1016.3%	Shares	Defined	2025-02-14
2024-03-31	$187,892	36,555	+0.0%	Shares	Defined	2024-05-15
2023-12-31	$209,436	36,551	-13.7%	Shares	Defined	2024-02-14
2023-09-30	$202,556	42,376	-58.0%	Shares	Defined	2023-11-14
2023-06-30	$428,701	100,871	+167.2%	Shares	Defined	2023-08-14
2023-03-31	$200,462	37,752	+2.4%	Shares	Defined	2023-05-22
2022-12-31	$231,586	36,877	-3.4%	Shares	Defined	2023-02-14
2022-09-30	$402,925	38,192	—	Shares	Defined	2022-11-14
No filing history on record for this holder in this stock.